About us
Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here?
Let's talk.
The other half of the equation is
blog posts from readers like you. So if you have an interest in science,
please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our
Privacy Policy and Site Disclaimer.
I was diagnosed with MS ten months ago and was told nothing about Low Dose Naltrexone by either of the two neurologists I was seeing at the time, even though one of them has since stated that he knows about the drug. Neurologists seem reluctant to prescribe LDN even though they know it can stop MS progressing for many people. The absence of clinical trials to test the effi efficacy of the drug, means that hundreds of thousands of MS sufferers worldwide are missing out on an opportunity to provide them with a better quality of life and possibly prevent their disease from progressing. God willing, a government, charity or individual with deep pockets will fund trials of this important drug. If you have MS or another auto immune disease, visit http://www.lowdosenaltrexone.org